Results

Total Results: 7,673 records

Showing results for "therapy".

  1. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
    August 01, 2014 - • Patient or surrogate decision maker declined or is unwilling to consent to therapies.
  2. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-annual-report-to-congress-2019.pdf
    January 01, 2019 - The National Institute of Mental Health works every day to transform the understanding and treatment … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy, … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy, … D Hormone Therapy With Combined Estrogen and Progestin in Postmenopausal Women: Primary Prevention … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy,
  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … The RCTs evaluated patients who were not on oral anticoagulation therapy (OAT) and had intracerebral … population targeted by the RCTs— patients with intracerebral hemorrhage who were not on anticoagulation therapy … There were insufficient studies to assess the impact of rFVIIa on patients taking oral anticoagulation therapy … with intracranial hemorrhage secondary to TBI who were not on anticoagulation therapy.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
    August 01, 2012 - The QI process is designed to raise the standards of the delivery of preventive, diagnostic, therapeutic … • In subanalysis at 5 years, QI–Therapy but not QI–Meds was effective within the minority population … A medication-focused intervention and a therapy-focused intervention decreased a disparity gap between … • QI–Meds and QI–Therapy decreased “probable unmet need” disparity gap between men and women from … 10% to 1% (QI–Meds) and 3% (QI–Therapy) at 24 months.
  5. www.ahrq.gov/sites/default/files/2024-12/selker-report.pdf
    January 01, 2024 - In ED treatment, although the lifesaving impact of coronary reperfusion by thrombolytic therapy and … the ACI-TIPI-IS for patients with symptoms of ACI and for patients w/ AMI who required reperfusion therapy … with thrombolytic therapy and coronary angioplasty. … Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction. … project phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapy
  6. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/50698/psn-pdf
    November 27, 2019 - Successful completion of this exercise can be therapeutic for patients and provides very useful information … means, lethal pain medications, and hot-spots for suicide by jumping.11  With respective to specific therapeutic … interventions, modest benefits have been documented for cognitive behavioral therapy (CBT) and dialectical … behavioral therapy (DBT), and some medications have been shown to reduce suicide rates as compared … Evidence-based medication treatments for “maintenance treatment” of alcohol use disorders are underutilized
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
    March 01, 2012 - What are the benefits and harms of immediate antibacterial, antiviral therapy, and/or hospitalization … antibiotic/antiviral therapy (vs. delaying until diagnostic workup is complete) in patients at high … their antibiotic treatment course.72 KQ 4. … In the absence of better data on harms and the costs of diagnostics and therapeutics or improved positive … The harms and costs of immediate therapy or management in high-risk patients have been poorly reported
  8. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27811/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  9. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27801/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  10. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27796/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  11. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27781/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  12. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27806/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  13. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27816/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  14. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27771/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  15. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27776/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0651-131114.pdf
    June 20, 2013 - Topic 0552 Low Back Pain NSD FINAL SJ Diagnosis and Treatment of Low … The nominator is also interested in the harms and benefits of the treatment options. … interventions for secondary prevention or prevention of flares of low back pain, and combination therapy … and related therapies, massage, and various psychological therapies) 6. … What are the comparative benefits and harms of combinations of therapies (versus single therapies or
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
    January 01, 2008 - the comparative effectiveness of disease-modifying antirheumatic drugs (DMARDs) and other medical treatments … for the treatment of juvenile idiopathic arthritis. … and have no disease-modifying properties)) Outcome(s): Potential harms and benefits of various treatments … subgroups of patients based on stage of disease, history of prior therapy, demographics, concomitant … therapies, or comorbidities?
  18. effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
    January 01, 2010 - gains once active therapy ends. … treatment or across treatments? … including music therapy and nutritional therapies intended to modify the core symptoms of ASD Comparators … interventions (e.g., autism, asperger, pervasive development, therapeutics, etc.). … This revision does not eliminate specific medical therapies from the review as treatments are typically
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
    December 09, 2009 - gains once active therapy ends. … treatment or across treatments? … including music therapy and nutritional therapies intended to modify the core symptoms of ASD Comparators … interventions (e.g., autism, asperger, pervasive development, therapeutics, etc.). … This revision does not eliminate specific medical therapies from the review as treatments are typically
  20. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/44231/psn-pdf
    January 22, 2016 - Just-in-time training for high-risk low-volume therapies: an approach to ensure patient safety. … Just-in-Time Training for High-Risk Low-Volume Therapies: An Approach to Ensure Patient Safety. … https://psnet.ahrq.gov/issue/just-time-training-high-risk-low-volume-therapies-approach-ensure-patient … and competency shortcomings for bedside nurses on an as-needed basis, given the demands of complex treatments … https://psnet.ahrq.gov/issue/just-time-training-high-risk-low-volume-therapies-approach-ensure-patient-safety